Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Bone Grafts and Substitutes Market Outlook (2022 to 2032)

The Bone Grafts and Substitutes Market was valued at around US$ 3 Billion in 2021. With a projected CAGR of 7.1% for the next ten years, the market is likely to reach a valuation of nearly US$ 6.3 Billion by the end of 2032. The recent surge in demand for allografts has triggered the demand for Bone Grafts and Substitutes.

Attribute Details
Bone Grafts and Substitutes Market Size (2021A) US$ 3 Billion
Bone Grafts and Substitutes Market Size (2022E) US$ 3.2 Billion
Projected Market Value (2032F) US$ 6.3 Billion
Global Market Growth Rate (2022 to 2032) 7.1% CAGR
Share of Top 5 Countries 67.35%
Key Companies Profiled
  • Allosource
  • DePuySynthes Inc.
  • Baxter
  • NuVasive Inc.
  • Smith & Nephew
  • Medtronic
  • Orthofix Holdings Inc.
  • TBF Tissue Engineering
  • Stryker Corporation
  • OrthoFix Medical Inc.
  • MedBone Biomaterial
  • SeaSpine

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sales Analysis of Bone Grafts and Substitutes from 2015 to 2021 Vs Market Outlook for 2022 to 2032

The global market for Bone Grafts and Substitutes expanded at a CAGR of 6.7% from 2015 to 2021. The market growth is projected to benefit from new product launches coupled with increasing requirements for dental bone grafts resulting in expanding product portfolios of key players shaping the Bone Grafts and Substitutes Industry.

The global Bone Grafts and Substitutes market is predicted to surge ahead at a CAGR of 7.1% and record sales worth US$ 6.3 Billion by the end of 2032. The USA will continue to be the largest market throughout the analysis period accounting for over US$ 1.1 Billion absolute dollar opportunity in the coming 10-year epoch.

What are the driving factors propelling the Bone Grafts and Substitutes Market?

The Bone Grafts and Substitutes Market is expected to grow during the forecast period owing to the fact that the global geriatric population is set to see a substantial increase during the forecast period. Data issued in 2020 by the U.N. of the total world populace, 727 Million accounted for the geriatric population. Taking into account, a 2020 article by NCBI, it is estimated that hip fractures incidences around the globe will see an increase to reach approximately 4.5 to 6.5 million by 2050, leading to a benefit in the joint reconstruction, long bone, and spinal fusion deployment mode of the Bone Grafts and Substitutes Market during the forecast period. Furthermore, a 2018 NCBI study states that lumbar spinal fusion surgeries saw an accelerated growth of 26 per 100,000 adults, further proving to be advantageous for the Bone Grafts and Substitutes Market.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Region-wise Insights

Why substantial growth is expected from Asia-Pacific Bone Grafts and Substitutes Market?

Growth in the medical tourism of the region owing to the cost-effectiveness of synthetic bone grafts, and healthcare improvements in the economies of China, Japan, and India are some of the key factors responsible for the growth of the Bone Grafts and Substitutes Market in Asia-Pacific. Especially in the developing economies of India and China, there is set to be significant growth in dental medical tourism owing to the cost-effectiveness of the dental segment by deployment mode of the Bone Grafts and Substitutes Market. Thus, during the forecast period, the market is expected to surge in the two countries.

The Bone Grafts and Substitutes Market is set to witness a CAGR of 9% in China to reach a market value of US$ 475.5 Million by the end of 2032. The market in APAC additionally envisions the positive impact of technological advancements by key market players. Medtronic with its launch of Grafton DBM, gave Japan its first-ever DBM in February 2019, thus opening greater avenues of market growth in the country. This is thus a substantial aid to the projected 9.2% CAGR that Japan envisioned for reaching a revenue of US$ 367.8 Million by the end of the forecast period. Moreover, The National Chemical Laboratory of India, in May 2017, succeeded in developing two new bone graft substitutes, namely PoroSyn and SynOst with the aim of augmentation and regeneration against bone loss due to a disease, injury, or an accident. Owing to all these factors, Asia-Pacific is forecasted to be a lucrative region for the Bone Grafts and Substitutes Market in the forthcoming years.

How is the Bone Grafts and Substitutes Market in North America Shaping Up?

The North American region accounts for approximately more than 40% of the market share and is expected to maintain its position in the Bone Grafts and Substitutes Market intact during the forecast period. The key reason for the growth of the Bone Grafts and Substitutes Market in North America is the growing requirement for dental bone grafts. Taking into account, a report published in the American Dental Association, implant surgeries, as of 2019, have a recorded 95% to 98% success rate proving to be advantageous for the Bone Grafts and Substitute market due to their assured results of the products. In the USA, around 5 million dental implant surgeries are completed annually on average. These surgeries, require bone-grafting preceding the implants due to their significant assistance in correct jaw placement, leading to better results. Hence, the market in North America is projected to reach significant value during the forecast period.

Country-wise Insights

What Role is the USA Expected to Play in the Global Bone Grafts and Substitutes Demand in the Forthcoming Years?

Expanding at a substantial CAGR of 6.9%, the Bone Grafts and Substitutes Market in the USA is forecasted to witness an absolute opportunity growth of US$ 1.1 Billion during the 10-year epoch to reach market revenue of US$ 2.4 Billion by the end of 2032. Growing incidences of joint disorders and sports injuries are some of the factors responsible for the growth of the Bone Grafts and Substitutes Market in the USA during the forthcoming forecast years. The National Spinal Cord Injury Statistical Center, USA has documented an average of 17,810 new spinal cord injury (SCIs) cases in the country. Surgeries involving bone grafts and related substitutes are the prevalent norm in the country for SCIs treatments. Hence, this is among the key factors responsible for an increase in Bone Grafts and Substitutes revenue during the forecasted years. The Centers for Disease Control and Prevention (CDC), anticipates that by 2030, around 67 Million people above 18 will be diagnosed with arthritis leading to an increase in the demand for bone grafts owing to their importance in arthritis treatment.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

How has the Increasing Use of Allografts Impacted the Bone Grafts and Substitutes Market?

The Allograft segment of the Bone Grafts and Substitutes Market is projected to witness a CAGR of 7% hence generating a bulk of the revenue to benefit the market. This segment finds extensive use in demineralized bone matrices (DBMs). The associated benefits of avoiding donor-site morbidity decreased operating and rehabilitating time, better safety, and diverse availability pertaining to sizes are some of the factors that aid in the positive impact of Allografts on the Bone Grafts and Substitutes Market. Furthermore, a 2021 report by the International Osteoporosis Foundation accounts that 8.9 million fractures associated with osteoporosis occur in a year on average. Among the common prevalent treatments for this degenerative bone disease is the application of allografts, thereby increasing the growth opportunities for the Allograft material type of the Bone Grafts and Substitutes Market.

How are Bone Grafts and Substitutes Demand Expected to Perform with their Growing Necessity in Spinal Fusion?

The Spinal Fusion segment of the Bone Grafts and Substitutes Market is expected to witness a CAGR of 6.9% during the forecast period. The rise in spinal fusion deployment may be a direct impact of the increasing adoption of bone grafts in spondylosyndesis. The growing necessity of bone grafts and substitutes is also enhanced by the consistent increase in cases of spinal deformities. Taking into account the data from a 2017 CDC report, around 60% of the aged population and 32% of the adult population in the USA were suffering from spinal deformities, owing to the spike in the geriatric population. This number is projected to further increase during the forecast period. Even in developing countries like India, around 20,000 spinal cord injury (SCIs) cases are added annually, leading to greater demand for bone grafts and substitutes in spinal fusion.

Competitive Analysis

Allosource, DePuySynthes Inc., Baxter, NuVasive Inc., Smith & Nephew, Medtronic, Orthofix Holdings Inc., TBF Tissue Engineering, Stryker Corporation, OrthoFix Medical Inc., MedBone Biomaterials, SeaSpine are among the key players driving the competitive landscape of the market. To expand their product portfolio and simultaneously capitalize on the growing market demand, many of these companies are adopting strategies such as mergers, acquisitions, and partnerships. The key market players are also increasing funding for various technological developments and associated research with the aim of gaining a competitive edge.

The key recent developments of Bone Grafts and Substitutes manufacturers are as follows:

  • In February 2022, Opus B.A., a highly efficient and synthetic bioactive bone graft solution, was launched by Orthofix Medical Inc. to benefit the process of cervical and lumbar spine fusions.
  • In February 2021, Simplify Medical was amassed by NuVasive Inc. to strengthen the company’s cervical portfolio, thus expanding its growth avenues during the forecast period.
  • In November 2020, the acquisition of Wright Medical Group N.V. was finalized by Stryker Corporation. The amassing of this medical equipment enterprise specializing in extremities and biologics is anticipated to aid in the enhancement of Stryker Corporation’s bone graft substitute portfolio, in order to expand its position in the market.
  • In July 2020, the FDA approved the Altapore Shape bioactive bone graft, by Baxter. The specific attributes of this bone graft among many include enhanced bone growth.

Key Segments Covered in Market Survey

The Bone Grafts and Substitutes Market is segmented based on material type, deployment mode, and region.

By Material Type:

  • Allograft
    • Demineralized Bone Matrix
    • Other Allografts
  • Synthetic
    • Ceramics
    • Composites
    • Polymers
    • Bone Morphogenic Proteins (BMP)

By Deployment Mode:

  • Craniomaxillofacial
  • Dental
  • Foot & Ankle
  • Joint Reconstruction
  • Long Bone
  • Spinal Fusion

By Region:

  • North America
    • The USA
    • Canada
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
  • Europe
    • Germany
    • United Kingdom
    • France
    • Russia
    • Italy
  • The Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • United Arab Emirates(UAE)
    • Nigeria
    • Egypt
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Colombia

Frequently Asked Questions

How much is the Bone Grafts and Substitutes market currently worth

The Bone Grafts and Substitutes Market was valued at US$ 3 Billion in 2021.

What is the Bone Grafts and Substitutes Market Forecast through 2032?

The Bone Grafts and Substitutes industry is set to witness a growth rate of 7.1% over the forecast period and be valued at US$ 6.3 Billion by 2032.

Whom are the key players shaping the Bone Grafts and Substitutes industry?

Allosource, DePuySynthes Inc., Baxter, NuVasive Inc., Smith & Nephew, Medtronic, Orthofix Holdings Inc., TBF Tissue Engineering, Stryker Corporation, OrthoFix Medical Inc., MedBone Biomaterials, SeaSpine are among the key players shaping the Bone Grafts and Substitutes industry.

What are the key factors driving the growth of the Bone Grafts and Substitutes market?

The increased use of allografts and the growing preference for spinal fusions in the Bone Grafts and Substitutes Market are favorably impacting the global demand for bone grafts and substitutes.

What is the USA market outlook for Bone Grafts and Substitutes?

The market in the USA is expected to reach a valuation of US$ 2.4 Billion during the forecast period along with a CAGR of 6.9%

Which region is expected to show significant growth during the forecast period?

The Asia Pacific market is expected to grow significantly during the forecast period mainly due to the increased research and development by the key market players, and the growing SCI cases in India and China.

Table of Content

1. Executive Summary | Bone Grafts and Substitutes Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Supply Chain Analysis

        3.4.1. Supply Side Participants and their Roles

            3.4.1.1. Producers

        3.4.2. List of Raw Material Suppliers

        3.4.3. List of Existing and Potential Buyers

    3.5. Investment Feasibility Matrix

    3.6. Value Chain Analysis

        3.6.1. Profit Margin Analysis

        3.6.2. Retailers

    3.7. PESTLE and Porter’s Analysis

    3.8. Regulatory Landscape

        3.8.1. By Key Regions

        3.8.2. By Key Countries

    3.9. Regional Parent Market Outlook

    3.10. Production and Consumption Statistics

4. Global Market Analysis 2015 to 2021 and Forecast, 2022 to 2032

    4.1. Historical Market Size Value (US$ Million) Analysis, 2015 to 2021

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Material Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Material Type, 2015 to 2021

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Material Type, 2022 to 2032

        5.3.1. Allograft

            5.3.1.1. Demineralized Bone Matrix

            5.3.1.2. Other Allografts

        5.3.2. Synthetic

            5.3.2.1. Ceramics

            5.3.2.2. Composites

            5.3.2.3. Polymers

    5.4. Y-o-Y Growth Trend Analysis By Material Type, 2015 to 2021

    5.5. Absolute $ Opportunity Analysis By Material Type, 2022 to 2032

6. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Deployment Mode

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Deployment Mode, 2015 to 2021

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Deployment Mode, 2022 to 2032

        6.3.1. Craniomaxillofacial

        6.3.2. Dental

        6.3.3. Foot & Ankle

        6.3.4. Joint Reconstruction

        6.3.5. Long Bone

        6.3.6. Spinal Fusion

    6.4. Y-o-Y Growth Trend Analysis By Deployment Mode, 2015 to 2021

    6.5. Absolute $ Opportunity Analysis By Deployment Mode, 2022 to 2032

7. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2015 to 2021

    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. East Asia

        7.3.5. South Asia

        7.3.6. Oceania

        7.3.7. Middle East and Africa(MEA)

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Country

    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021

    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        8.2.1. By Country

            8.2.1.1. USA

            8.2.1.2. Canada

        8.2.2. By Material Type

        8.2.3. By Deployment Mode

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Material Type

        8.3.3. By Deployment Mode

    8.4. Key Takeaways

9. Latin America Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Argentina

            9.2.1.4. Rest of Latin America

        9.2.2. By Material Type

        9.2.3. By Deployment Mode

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Material Type

        9.3.3. By Deployment Mode

    9.4. Key Takeaways

10. Europe Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. Italy

            10.2.1.3. France

            10.2.1.4. United Kingdom

            10.2.1.5. Spain

            10.2.1.6. Russia

            10.2.1.7. BENELUX

            10.2.1.8. Rest of Europe

        10.2.2. By Material Type

        10.2.3. By Deployment Mode

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Material Type

        10.3.3. By Deployment Mode

    10.4. Key Takeaways

11. East Asia Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. South Korea

        11.2.2. By Material Type

        11.2.3. By Deployment Mode

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Material Type

        11.3.3. By Deployment Mode

    11.4. Key Takeaways

12. South Asia Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Thailand

            12.2.1.3. Malaysia

            12.2.1.4. Indonesia

            12.2.1.5. Rest of South Asia

        12.2.2. By Material Type

        12.2.3. By Deployment Mode

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Material Type

        12.3.3. By Deployment Mode

    12.4. Key Takeaways

13. Oceania Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        13.2.1. By Country

            13.2.1.1. Australia

            13.2.1.2. New Zealand

        13.2.2. By Material Type

        13.2.3. By Deployment Mode

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Material Type

        13.3.3. By Deployment Mode

    13.4. Key Takeaways

14. MEA Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. Rest of Middle East and Africa(MEA)

        14.2.2. By Material Type

        14.2.3. By Deployment Mode

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Material Type

        14.3.3. By Deployment Mode

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2021

            15.1.2.1. By Material Type

            15.1.2.2. By Deployment Mode

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2021

            15.2.2.1. By Material Type

            15.2.2.2. By Deployment Mode

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2021

            15.3.2.1. By Material Type

            15.3.2.2. By Deployment Mode

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2021

            15.4.2.1. By Material Type

            15.4.2.2. By Deployment Mode

    15.5. Argentina

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2021

            15.5.2.1. By Material Type

            15.5.2.2. By Deployment Mode

    15.6. Germany

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2021

            15.6.2.1. By Material Type

            15.6.2.2. By Deployment Mode

    15.7. Italy

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2021

            15.7.2.1. By Material Type

            15.7.2.2. By Deployment Mode

    15.8. France

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2021

            15.8.2.1. By Material Type

            15.8.2.2. By Deployment Mode

    15.9. United Kingdom

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2021

            15.9.2.1. By Material Type

            15.9.2.2. By Deployment Mode

    15.10. Spain

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2021

            15.10.2.1. By Material Type

            15.10.2.2. By Deployment Mode

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2021

            15.11.2.1. By Material Type

            15.11.2.2. By Deployment Mode

    15.12. BENELUX

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2021

            15.12.2.1. By Material Type

            15.12.2.2. By Deployment Mode

    15.13. China

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2021

            15.13.2.1. By Material Type

            15.13.2.2. By Deployment Mode

    15.14. Japan

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2021

            15.14.2.1. By Material Type

            15.14.2.2. By Deployment Mode

    15.15. South Korea

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2021

            15.15.2.1. By Material Type

            15.15.2.2. By Deployment Mode

    15.16. India

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2021

            15.16.2.1. By Material Type

            15.16.2.2. By Deployment Mode

    15.17. Thailand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2021

            15.17.2.1. By Material Type

            15.17.2.2. By Deployment Mode

    15.18. Malaysia

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2021

            15.18.2.1. By Material Type

            15.18.2.2. By Deployment Mode

    15.19. Indonesia

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2021

            15.19.2.1. By Material Type

            15.19.2.2. By Deployment Mode

    15.20. Australia

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2021

            15.20.2.1. By Material Type

            15.20.2.2. By Deployment Mode

    15.21. New Zealand

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2021

            15.21.2.1. By Material Type

            15.21.2.2. By Deployment Mode

    15.22. GCC Countries

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2021

            15.22.2.1. By Material Type

            15.22.2.2. By Deployment Mode

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Material Type

        16.3.3. By Deployment Mode

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Allosource

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

                17.1.1.5.2. Product Strategy

                17.1.1.5.3. Channel Strategy

        17.1.2. DePuySynthes Inc.

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

                17.1.2.5.2. Product Strategy

                17.1.2.5.3. Channel Strategy

        17.1.3. Baxter

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

                17.1.3.5.2. Product Strategy

                17.1.3.5.3. Channel Strategy

        17.1.4. NuVasive Inc.

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

                17.1.4.5.2. Product Strategy

                17.1.4.5.3. Channel Strategy

        17.1.5. Smith & Nephew

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

                17.1.5.5.2. Product Strategy

                17.1.5.5.3. Channel Strategy

        17.1.6. Medtronic

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

                17.1.6.5.2. Product Strategy

                17.1.6.5.3. Channel Strategy

        17.1.7. Orthofix Holdings Inc.

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

                17.1.7.5.2. Product Strategy

                17.1.7.5.3. Channel Strategy

        17.1.8. TBF Tissue Engineering

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

                17.1.8.5.2. Product Strategy

                17.1.8.5.3. Channel Strategy

        17.1.9. Stryker Corporation

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

                17.1.9.5.2. Product Strategy

                17.1.9.5.3. Channel Strategy

        17.1.10. OrthoFix Medical Inc.

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

                17.1.10.5.2. Product Strategy

                17.1.10.5.3. Channel Strategy

        17.1.11. MedBone Biomaterial

            17.1.11.1. Overview

            17.1.11.2. Product Portfolio

            17.1.11.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.11.4. Sales Footprint

            17.1.11.5. Strategy Overview

                17.1.11.5.1. Marketing Strategy

                17.1.11.5.2. Product Strategy

                17.1.11.5.3. Channel Strategy

        17.1.12. SeaSpine

            17.1.12.1. Overview

            17.1.12.2. Product Portfolio

            17.1.12.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.12.4. Sales Footprint

            17.1.12.5. Strategy Overview

                17.1.12.5.1. Marketing Strategy

                17.1.12.5.2. Product Strategy

                17.1.12.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Explore Healthcare Insights

View Reports

Bone Grafts and Substitutes Market